Libera Gaming Operations, which operates pachinko gaming halls in Japan, raised the proposed deal size for its upcoming IPO on Monday. The Tokyo, Japan-based company now plans to raise $19 million by offering 3.8 million shares at a price range of $4 to $6....read more
After a period of uneven performance, the biotech IPO market is beginning to show signs of renewed momentum. On Monday, radiopharmaceutical oncology biotech Aktis Oncology (AKTS) launched a $200 million IPO; two days later, the company upsized the deal by 50%...read more
Updated Monday, 1/5. One sizable deal is scheduled for the week ahead, with one smaller deal tentatively scheduled. Solid tumor biotech Aktis Oncology (AKTS) plans to raise $200 million at an $860 million market cap. The company is a Phase 1...read more
Japanese gaming hall operator Libera Gaming Operations triples share offering ahead of $19 million US IPO
Libera Gaming Operations, which operates pachinko gaming halls in Japan, raised the proposed deal size for its upcoming IPO on Monday. The Tokyo, Japan-based company now plans to raise $19 million by offering 3.8 million shares at a price range of $4 to $6....read more
US IPO Week Ahead: Markets set for a quiet week after year’s first sizable IPO
...read more
Biotech IPOs are back: Why 2026 could mark a hot year for the sector
After a period of uneven performance, the biotech IPO market is beginning to show signs of renewed momentum. On Monday, radiopharmaceutical oncology biotech Aktis Oncology (AKTS) launched a $200 million IPO; two days later, the company upsized the deal by 50%...read more
US IPO Week Ahead: Aktis Oncology set to open 2026 IPO Market
Updated Monday, 1/5. One sizable deal is scheduled for the week ahead, with one smaller deal tentatively scheduled. Solid tumor biotech Aktis Oncology (AKTS) plans to raise $200 million at an $860 million market cap. The company is a Phase 1 ...read more